Zusammenfassung
Samenvatting van alle colleges - Metabolism and Toxicology (WBFA016-05)
- Kurs
- Hochschule
Samenvatting van alle colleges van het vak Metabolism and toxicology gegeven aan de Rijksuniversiteit Groningen
[ Mehr anzeigen ]vorschau 4 aus 39 Seiten
Vorschau 4 aus 39 Seiten
In den Einkaufswagen
In den Einkaufswagen
Verkäufer
Folgen
sarahwierda
Inhaltsvorschau
Metabolism and ToxicologyLecture 1: Introduction (van der Graaf)
Metabolism: chemical transformation that compounds undergo in the body body do compound.
Toxicology: adverse effects of chemicals on organisms compound to body.
Paracetamol is a very lipophilic compound. It is a save painkiller but deadly with a high dose (ong. 10
times the maximum daily dose = 30 gram)
Absorption and elimination
- Lipophilic compounds pass membranes and be absorbed.
- Ionized compounds do not pass membranes easy anymore.
- Water-soluble compounds difficult to absorb but are easily excreted.
- Fat-soluble compounds absorbed easy but can keep circulating in the body for a long
time.
Lipophilic compounds can bind to proteins, to get soluble protein too big to pass filter slows
clearance.
- Albumin: plasma protein, not filtered in glomerulus.
Compounds need to be hydrophilic/water-soluble to be excreted. Lipophilic drugs need to be
metabolised to make it water-soluble in order to be eliminated.
Toxicity: metabolism leads to reactive metabolites.
Metabolism of paracetamol
- Normal pathway: Paracetamol is converted to
hydrophilic compound which is easy to excrete.
- Toxic pathway: Paracetamol is metabolized to an N-
hydroxyl metabolite unstable, so it changes to NAPQI
toxic.
Normal pathway is faster will be chosen first. When all
routes are saturated toxicity.
Toxification / bioactivation: metabolite more toxic than parent compound.
Detoxification: metabolite less toxic than parent compound.
Adverse effect: any unwanted effect of a drug that interferes with the normal function and
adaptability of the body to the environment.
Undesirable effect: on/off target
- On-target toxicity: due to exaggerated pharmacological effect or on same receptor but on
different tissue. On same receptor.
- Off-target toxicity: via completely different mechanism (different target) than the
pharmacological effect. Effect on the incorrect receptor.
1
,Targets for toxins:
- Receptors
- Proteins (enzymes/transporters)
- Membrane-lipids
- DNA/RNA (can lead to tumors)
- Ca2+ homeostasis
- Ion channels
- Mitochondria (damage no energy)
Immunotoxicity: toxic effects by immune system, response to damage somewhere in the body.
- Due to toxic effects on immune system itself: toxic effect on B or T lymphocytes.
- Due to suppression/stimulation of the immune system.
Same dose ≠ same exposure
These can all affect the exposure, even in the dose is not different.
- Differences in exposure routes.
- Species/interindividual differences in ADME.
- Accumulation.
- Time (dose*time).
- Interactions (induction/inhibition).
Toxicity is determined by:
These determine the risks and the safety of the compound.
- Characteristics of the compound: hazard Compound potentially has an adverse effect.
- Amount/dose/concentration: degree of exposure to the hazard.
Toxicity depends on the exposure (= AUC of the concentration-time curve).
Parameters
- LD50: dose needed to kill 50% of population. Low = toxic.
- TD50: dose needed for 50% of max toxic effect / where 50% of population shows toxic effect.
- TC50: plasma concentration for 50% of max toxic effect / where 50% of pop shows toxic
effect.
- ED50: dose for 50% of desired effect / when 50% of population shows desired effect.
- EC50: plasma concentration for 50% of desired effect / when 50% of population shows
desired effect.
LOAEL: Lowest Observed Adverse Effect Level first tested dose/concentration that gives toxic
effect.
NOAEL: No Observed Adverse Effect Level: just below LOAEL.
ADI: acceptable daily intake.
Risk assessment
- Hazard: anything that can cause harm (biological property/potential).
- Risk: greatness of chance that hazard will harm someone (chance on toxicity.
Measures for safety
- Therapeutic index: TD50 / ED50.
- Margin of safety MOS: TD1 / ED99
2
,Drug testing
Toxicity is tested first in vitro on animals on healthy people on patients
Toxicology in drug development
- Research phase: screening for toxicology/metabolism (in vitro).
- Development phase: ADME (in vitro + in vivo).
- Clinical phase: human PK/toxicity/safety.
- Post-marketing: side effects, pharmacovigilance, PMS.
ADR’s are a major clinical problem.
When a drug is put on the market, the safety data is limited.
Lareb: the central collection point for all side effects of pharmaceutical drugs in the Netherlands.
REACH: Registration, Evaluation and Authorization of CHemical substances. Data about safe use of
chemical substances. European community regulations.
3
, Lecture 2: ADME & Toxicokinetics (Olinga)
ADME determines the exposure to the final toxic compound.
Toxicity
- Local toxicity: harmful without being absorbed.
- Systemic toxicity: harmful after uptake in the systemic circulation.
Bioavailability: fraction of dose that reaches the systemic circulation. Decreased by the first pass
effect (metabolism in the intestine and liver).
- Bioavailability = AUCoral/AUCi.v.
Absorption takes place in the epithelial cells.
Membrane transport
Membranes are lipophilic hydrophobic compounds are taken up easily. Hydrophilic compounds
are taken up via transporters.
- Passive transport: due to concentration difference. Via simple diffusion, a channel, or a
carrier. Lipophilic drugs can diffuse, hydrophilic drugs need to be carrier mediated.
- Active transport: against electrochemical gradient energy required. Transport through a
channel.
Absorption in GI
Depends on:
- pH (varies from 2-7).
- Blood flow.
- Metabolism in intestinal epithelial.
- Transporters in intestinal epithelium.
- Nutritional status.
- Intestinal contractions.
- Bacteria (metabolism, bioactivation, detoxification).
Surface small intestine = 250 m2.
Compound properties that affect uptake
- Lipophilicity
- Pka
- Affinity for uptake carriers
- Size
- Solubility
- Affinity for metabolic enzymes.
- Affinity for excretion carriers (P-gp).
Factors influencing intestinal toxicity (exposure)
- High concentrations in intestinal lumen after oral administration.
- Degree of uptake/excretion in intestinal epithelium.
- Metabolism (bacteria, through wall epithelial cells, pH)
Enterohepatic circulation: compound is metabolised in the liver excreted back into GI tract
taken up by the liver again.
4
Alle Vorteile der Zusammenfassungen von Stuvia auf einen Blick:
Garantiert gute Qualität durch Reviews
Stuvia Verkäufer haben mehr als 700.000 Zusammenfassungen beurteilt. Deshalb weißt du dass du das beste Dokument kaufst.
Schnell und einfach kaufen
Man bezahlt schnell und einfach mit iDeal, Kreditkarte oder Stuvia-Kredit für die Zusammenfassungen. Man braucht keine Mitgliedschaft.
Konzentration auf den Kern der Sache
Deine Mitstudenten schreiben die Zusammenfassungen. Deshalb enthalten die Zusammenfassungen immer aktuelle, zuverlässige und up-to-date Informationen. Damit kommst du schnell zum Kern der Sache.
Häufig gestellte Fragen
Was bekomme ich, wenn ich dieses Dokument kaufe?
Du erhältst eine PDF-Datei, die sofort nach dem Kauf verfügbar ist. Das gekaufte Dokument ist jederzeit, überall und unbegrenzt über dein Profil zugänglich.
Zufriedenheitsgarantie: Wie funktioniert das?
Unsere Zufriedenheitsgarantie sorgt dafür, dass du immer eine Lernunterlage findest, die zu dir passt. Du füllst ein Formular aus und unser Kundendienstteam kümmert sich um den Rest.
Wem kaufe ich diese Zusammenfassung ab?
Stuvia ist ein Marktplatz, du kaufst dieses Dokument also nicht von uns, sondern vom Verkäufer sarahwierda. Stuvia erleichtert die Zahlung an den Verkäufer.
Werde ich an ein Abonnement gebunden sein?
Nein, du kaufst diese Zusammenfassung nur für 6,49 €. Du bist nach deinem Kauf an nichts gebunden.
Kann man Stuvia trauen?
4.6 Sterne auf Google & Trustpilot (+1000 reviews)
45.681 Zusammenfassungen wurden in den letzten 30 Tagen verkauft
Gegründet 2010, seit 14 Jahren die erste Adresse für Zusammenfassungen